Bimi(OTC) BIMI

Market Cap$1.40K

Since IPO (2006)-100%

5 Year-100%

1 Year-50%

1 Month+0%

$0.00

+0.00%

+0.00Today

Bimi last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-13

Bimi stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-08-06
1 month	+0%	USD 0.00	2026-07-14
3 month	+9,900%	USD 0.00	2026-05-14
Year to date	+0%	USD 0.00	2025-12-31
1 year	-50%	USD 0.00	2025-08-13
3 year	-100%	USD 2.39	2023-08-14
5 year	-100%	USD 45.93	2021-08-13
Since inception	-100%	USD 300.00	2006-12-18

Bimi Financials at a Glance

Market Cap

$1.40K

Revenue (TTM)

$5.85M

Net Income (TTM)

-$14.76M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

10.18 (High)

Dividend

$0.00

Beta (Volatility)

10.18 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jan 28, 2025

Dividend

$0.00

Beta (Volatility)

10.18 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Jan 28, 2025

BIMI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bimi

BIMI International Medical Inc. is a healthcare enterprise based in Chongqing, China, specializing in the supply and sale of medical devices, pharmaceuticals, and health-related products. Established in 2000, the company operates across four main divisions: wholesale pharmaceuticals, wholesale medical devices, medical services, and retail pharmacies.

Products and Services

Wholesale distribution of specialized medical equipment
Retail pharmacies offering prescription and over-the-counter drugs
Medical services within hospital environments

Growth Outlook

Recent quarterly revenue of $2.52 million indicates potential recovery
Quarterly gross profit margin improved to 4.56% in Q3 2023
Expansion of retail pharmacy network may drive future sales growth

Financial Highlights

Net income of -$3.13 million reported for Q3 2023
Operating income improved to -$3.15 million in Q3 2023
Cash and cash equivalents totaled $994,131 as of September 30, 2023

BIMI International Medical Inc. has shown signs of recovery in its financial performance, with a notable increase in revenue and improvements in gross profit margins. The company’s diverse product offerings and strategic focus on expanding its retail pharmacy network position it well for future growth. Despite recent net losses, the operational improvements and cash management strategies may enhance its financial stability moving forward. Investors may find the company's trajectory and market positioning within the healthcare sector noteworthy.

AI Generated • Jul 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

296

CEO

Tie Wei Song

Website

www.usbimi.com

Headquarters

New York, NY 10022, US

BIMI Financials

Key Financial Metrics (TTM)

Gross Margin

16.48%

Operating Margin

-129.65%

Net Income Margin

-189.29%

Return on Equity

-293.85%

Return on Capital

-161.40%

Return on Assets

-62.70%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.40K

Shares Outstanding

13.96M

Volume

Avg. Volume

1.61K

Financials (TTM)

Gross Profit

-$3.06M

Operating Income

-$8.68M

EBITDA

-$10.47M

Operating Cash Flow

-$2.16M

Capital Expenditure

-$603.90K

Free Cash Flow

-$2.77M

Cash & ST Invst.

$994.13K

Total Debt

$4.47M

Bimi Performance Analysis

Bimi annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 21,319,610	N/A
2022	2022-12-31	USD 11,830,379	-44.5%

Bimi sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	-174.3%
Q1	2023-03-31	158.9%
Q2	2023-06-30	73.8%
Q3	2023-09-30	-54.6%

Bimi annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD -3,261.90	N/A
2022	2022-12-31	USD -8.39	-99.7%

Bimi sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2022-12-31	-158.7%
Q1	2023-03-31	94.4%
Q2	2023-06-30	200.0%
Q3	2023-09-30	-313.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2023YOY CHG

Revenue

$2.52M

-65.5%

Gross Profit

$115.16K

-92.7%

Gross Margin

4.56%

N/A

Market Cap

$1.40K

N/A

Market Cap/Employee

$4.73

N/A

Employees

296

N/A

Net Income

-$3.13M

+19.4%

EBITDA

-$3.10M

-37.4%

Quarterly Fundamentals

Name

Q3 2023YOY CHG

Total Cash

$994.13K

-5.0%

Total Debt

$4.47M

-64.6%

Accounts Receivable

$5.40M

-41.4%

Inventory

$7.09M

+476.0%

Long Term Debt

$2.47M

-66.2%

Short Term Debt

$2.00M

-34.6%

Return on Assets

-62.70%

N/A

Return on Invested Capital

-1.48%

N/A

Free Cash Flow

-$2.09M

+74.8%

Operating Cash Flow

-$1.48M

+82.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FSPMFusionPharm, Inc.

FSPMFusionPharm, Inc.$0.00+0.00%

BGMDBG Medicine, Inc.

BGMDBG Medicine, Inc.$0.00+0.00%

GRPIGrupo International Inc.

GRPIGrupo International Inc.$0.00+0.00%

EFTReFFECTOR Therapeutics, Inc.

EFTReFFECTOR Therapeutics, Inc.$0.00+0.00%

UTRSMinerva Surgical, Inc.

UTRSMinerva Surgical, Inc.$0.00+0.00%

ADYXAdynxx, Inc.

ADYXAdynxx, Inc.$0.00+0.00%

CFRXQContraFect Corp.

CFRXQContraFect Corp.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.61-0.02%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$146.23+0.04%

IPSTIp Strategy

IPSTIp Strategy$7.39+2.36%

NVDANvidia

NVDANvidia$225.01-0.00%

NOKNokia

NOKNokia$10.78+0.00%

INTCIntel

INTCIntel$103.49+0.01%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$8.69+0.02%

Questions About BIMI

What is the current price of Bimi?

Bimi is trading at $0.00 per share.

What is the 52-week range for Bimi?

Over the past 52 weeks, Bimi has traded between $0.00 and $0.00.

How much debt does Bimi have?

As of the most recent reporting period, Bimi reported total debt of $5.46M.

How much cash does Bimi have on hand?

Bimi reported $2.34M in cash and cash equivalents in its most recent financial results.

What is Bimi’s dividend yield?

Bimi does not currently have a dividend yield.

Bimi(OTC) BIMI

Bimi Financials at a Glance

BIMI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bimi

BIMI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bimi Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BIMI

What is the current price of Bimi?

What is the 52-week range for Bimi?

How much debt does Bimi have?

How much cash does Bimi have on hand?

What is Bimi’s dividend yield?

Premium Investing Services